Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ORTHOPEDIATRICS CORP Director's Dealing 2018

Sep 14, 2018

32906_dirs_2018-09-14_847a4905-d7df-45df-b705-c6918ee4852d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORTHOPEDIATRICS CORP (KIDS)
CIK: 0001425450
Period of Report: 2018-09-13

Reporting Person: Unger Kevin (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-09-13 Common Stock M 196 $30.97 Acquired 2400 Direct
2018-09-13 Common Stock S 1000 $33.22 Disposed 1400 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-09-13 Stock Option (Right to Buy) $30.97 M 196 Disposed 2023-09-10 Common Stock (196.0) Direct

Footnotes

F1: Includes restricted stock awards totaling 1,400 shares subject to vesting requirements.

F2: The stock option is fully vested and immediately exercisable.